National risk prediction model for perioperative mortality in non-cardiac surgery

被引:44
作者
Campbell, D. [1 ]
Boyle, L. [2 ]
Soakell-Ho, M. [5 ]
Hider, P. [6 ]
Wilson, L. [8 ]
Koea, J. [3 ]
Merry, A. F. [1 ,4 ]
Frampton, C. [7 ]
Short, T. G. [1 ,4 ]
机构
[1] Auckland City Hosp, Dept Anaesthesia & Perioperat Med, 2 Pk Rd, Auckland 1023, New Zealand
[2] Orion Hlth, Auckland, New Zealand
[3] North Shore Hosp, Dept Surg, Upper Gastrointestinal Unit, Auckland, New Zealand
[4] Univ Auckland, Dept Anaesthesiol, Auckland, New Zealand
[5] Pegasus Hlth, Christchurch, New Zealand
[6] Univ Otago, Dept Populat Hlth, Christchurch, New Zealand
[7] Univ Otago, Dept Biostat, Christchurch, New Zealand
[8] Wellington Reg Hosp, Dept Anaesthesia & Pain Management, Wellington, New Zealand
关键词
INDIVIDUAL PROGNOSIS; DIAGNOSIS TRIPOD; TOOL; SCORE;
D O I
10.1002/bjs.11232
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Many multivariable models to calculate mortality risk after surgery are limited by insufficient sample size at development or by application to cohorts distinct from derivation populations. The aims of this study were to validate the Surgical Outcome Risk Tool (SORT) for a New Zealand population and to develop an extended NZRISK model to calculate 1-month, 1-year and 2-year mortality after non-cardiac surgery. Methods Data from the New Zealand National Minimum Data Set for patients having surgery between January 2013 and December 2014 were used to validate SORT. A random 75 per cent split of the data was used to develop the NZRISK model, which was validated in the other 25 per cent of the data set. Results External validation of SORT in the 360 140 patients who underwent surgery in the study period showed good discrimination (area under the receiver operating characteristic curve (AUROC) value of 0 center dot 906) but poor calibration (McFadden's pseudo-R-2 0 center dot 137, calibration slope 5 center dot 32), indicating it was invalid in this national surgical population. Internal validation of the NZRISK model, which incorporates sex and ethnicity in addition to the variables used in SORT for 1-month, 1-year and 2-year outcomes, demonstrated excellent discrimination with AUROC values of 0 center dot 921, 0 center dot 904 and 0 center dot 895 respectively, and excellent calibration (McFadden's pseudo-R-2 0 center dot 275, 0 center dot 308 and 0 center dot 312 respectively). Calibration slopes were 1 center dot 12, 1 center dot 02 and 1 center dot 02 respectively. Conclusion The SORT performed poorly in this national population. However, inclusion of sex and ethnicity in the NZRISK model improved performance. Calculation of mortality risk beyond 30 days after surgery adds to the utility of this tool for shared decision-making.
引用
收藏
页码:1549 / 1557
页数:9
相关论文
共 21 条
[1]  
[Anonymous], 2017, BRIT J ANAESTH, V119, P553, DOI [10.1093/bja/aew472, 10.1093/bja/aew316]
[2]   Development and Evaluation of the Universal ACS NSQIP Surgical Risk Calculator: A Decision Aid and Informed Consent Tool for Patients and Surgeons [J].
Bilimoria, Karl Y. ;
Liu, Yaoming ;
Paruch, Jennifer L. ;
Zhou, Lynn ;
Kmiecik, Thomas E. ;
Ko, Clifford Y. ;
Cohen, Mark E. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (05) :833-+
[3]  
Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.1016/j.jclinepi.2014.11.010, 10.1038/bjc.2014.639, 10.1136/bmj.g7594, 10.1016/j.eururo.2014.11.025, 10.7326/M14-0697, 10.1186/s12916-014-0241-z, 10.1002/bjs.9736, 10.7326/M14-0698]
[4]   2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J].
Fleisher, Lee A. ;
Fleischmann, Kirsten E. ;
Auerbach, Andrew D. ;
Barnason, Susan A. ;
Beckman, Joshua A. ;
Bozkurt, Biykem ;
Davila-Roman, Victor G. ;
Gerhard-Herman, Marie D. ;
Holly, Thomas A. ;
Kane, Garvan C. ;
Marine, Joseph E. ;
Nelson, M. Timothy ;
Spencer, Crystal C. ;
Thompson, Annemarie ;
Ting, Henry H. ;
Uretsky, Barry F. ;
Wijeysundera, Duminda N. .
CIRCULATION, 2014, 130 (24) :2215-2245
[5]  
Health Quality and Safety Commission New Zealand, 2017, 6 REP PER MORT REV C
[6]   A coronary heart disease prediction model: the Korean Heart Study [J].
Jee, Sun Ha ;
Jang, Yangsoo ;
Oh, Dong Joo ;
Oh, Byung-Hee ;
Lee, Sang Hoon ;
Park, Seong-Wook ;
Seung, Ki-Bae ;
Mok, Yejin ;
Jung, Keum Ji ;
Kimm, Heejin ;
Yun, Young Duk ;
Baek, Soo Jin ;
Lee, Duk Chul ;
Choi, Sung Hee ;
Kim, Moon Jong ;
Sung, Jidong ;
Cho, BeLong ;
Kim, Eung Soo ;
Yu, Byung-Yeon ;
Lee, Tae-Yong ;
Kim, Jong Sung ;
Lee, Yong-Jin ;
Oh, Jang-Kyun ;
Kim, Sung Hi ;
Park, Jong-Ku ;
Koh, Sang Baek ;
Park, Sat Byul ;
Lee, Soon Young ;
Yoo, Cheol-In ;
Kim, Moon Chan ;
Kim, Hong-Kyu ;
Park, Joo-sung ;
Kim, Hyeon Chang ;
Lee, Gyu Jang ;
Woodward, Mark .
BMJ OPEN, 2014, 4 (05)
[7]   Preoperative Score to Predict Postoperative Mortality (POSPOM) Derivation and Validation [J].
Le Manach, Yannick ;
Collins, Gary ;
Rodseth, Reitze ;
Le Bihan-Benjamin, Christine ;
Biccard, Bruce ;
Riou, Bruno ;
Devereaux, P. J. ;
Landais, Paul .
ANESTHESIOLOGY, 2016, 124 (03) :570-579
[8]   Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study [J].
Liu, J ;
Hong, YL ;
D'Agostino, RB ;
Wu, ZS ;
Wang, W ;
Sun, JY ;
Wilson, PWF ;
Kannel, WB ;
Zhao, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (21) :2591-2599
[9]  
Ministry of Health, 2015, NAT MIN DAT HOSP EV
[10]  
Ministry of Health, ETHN COD TABL